VanEck Pharmaceutical ETF
PPH
#1025
ETF rank
HK$9.29 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
HK$775.00
Share price
-0.24%
Change (1 day)
13.15%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of December 2025: 0.36%

Net Expense Ratio

Net Expense Ratio as of December 2025: 0.36%